Wegovy vs other weight loss medications: How to choose the right GLP-1 for your goals

Choosing the right GLP-1 medication for weight loss is one of the most common—and most important—questions patients bring to a weight management visit. Wegovy vs other weight loss medications isn’t a simple comparison: semaglutide, liraglutide, and tirzepatide each work differently, and the best choice depends on your health goals, tolerability, and insurance coverage. This guide breaks down the most common GLP-1 options so you can have a more informed conversation with your provider.

What are GLP-1 medications and how do they work?

GLP-1 receptor agonists are a class of injectable medications originally developed for type 2 diabetes. They mimic glucagon-like peptide-1, a hormone that regulates appetite, blood sugar, and how the body processes food. When prescribed at higher doses specifically for weight management, they help patients feel fuller longer, eat less, and lose significant body mass.

FDA-approved GLP-1 options for chronic weight management include:

• Wegovy (semaglutide 2.4 mg weekly)
• Saxenda (liraglutide 3.0 mg daily)
• Zepbound (tirzepatide 2.4–5.6 mg weekly)
• Mounjaro (tirzepatide, used off-label)

Each has distinct characteristics that make it suitable for different patients.

Wegovy: The most widely prescribed GLP-1 for weight loss

Wegovy is semaglutide at the highest approved dose for weight loss. Clinical trials show patients lose an average of 15% of body weight over 68 weeks when combined with lifestyle changes.

Strengths:

• Well-studied with strong long-term safety data
• Once-weekly injection is convenient
• Broadest insurance acceptance of any GLP-1 weight loss medication
• Lower out-of-pocket cost for many patients

Considerations:

• 12-week dose escalation before reaching the full 2.4 mg dose
• Nausea is common in the first weeks
• May require prior authorization depending on your plan

Saxenda: A daily GLP-1 injection alternative

Saxenda uses liraglutide and requires daily injections rather than weekly ones. Average weight loss is around 5–6% of body weight over one year—meaningful, though less than semaglutide or tirzepatide.

Strengths:

• Longer track record (available since 2014)
• Some patients tolerate daily low-dose injections better than weekly higher-dose ones
• Flexible dosing schedule

Considerations:

• Less weight loss compared to Wegovy or Zepbound
• Daily injections are less convenient for most patients
• Higher cumulative medication cost; insurance coverage varies more widely

Zepbound and Mounjaro: The dual-action GLP-1 option

Zepbound is tirzepatide—the first GLP-1/GIP receptor agonist approved specifically for weight loss. It activates two hormone pathways instead of one. Mounjaro is the same compound marketed for type 2 diabetes.

Strengths:

• Highest average weight loss in clinical trials (22% over 72 weeks)
• Once-weekly injection, like Wegovy
• More potent appetite suppression for many patients
• May improve metabolic markers beyond weight loss alone

Considerations:

• Newer with a shorter real-world track record
• Insurance coverage still evolving; some plans restrict or deny coverage
• Higher rates of gastrointestinal side effects in some patients

How to choose between Wegovy and other weight loss medications

Understanding the differences is a start—now let’s apply them to your situation.

Efficacy goals. Patients seeking maximum weight loss may benefit most from tirzepatide’s dual-action mechanism. Those with more modest goals or lower side-effect tolerance might do better starting with Wegovy or Saxenda.

Injection preference. Weekly dosing suits most patients. Daily dosing works for those with established needle comfort or who prefer more control over their schedule.

Tolerability history. If you’ve had significant nausea or GI issues with a GLP-1 before, slower titration or a different agent may be warranted—always discuss prior reactions with your prescribing physician. In my practice, I’ve found that patients who are warned accurately about what GLP-1 nausea actually feels like—quieter than expected, more of a calm signal that the body is done rather than violent retching—tend to tolerate side effects significantly better than those who are caught off guard.

Insurance and cost. Wegovy typically has the broadest insurance acceptance. Confirm coverage before starting to avoid financial surprises mid-treatment.

Comorbid conditions. Patients with type 2 diabetes may benefit from tirzepatide’s glucose-lowering effects. Those with a personal or family history of medullary thyroid cancer should avoid all GLP-1 medications.

Individual metabolic response. Some patients lose weight steadily on one medication and plateau on another. That’s biology, not failure—and it’s exactly why ongoing provider follow-up matters. I also tell patients that the goal isn’t necessarily the highest dose on the label; it’s the highest dose you can successfully live with, and meaningful results regularly happen below the maximum.

What to expect when you start treatment

Whichever medication you choose, treatment begins at a low dose and increases gradually over weeks or months to minimize nausea and help your body adjust.

Patients should expect:

• Weekly or daily injections depending on the medication
• Appetite suppression that develops over days to weeks
• Initial nausea that typically resolves within 4–6 weeks
• Steady weight loss over months, not days
• Regular follow-up to monitor progress and side effects

The bottom line on Wegovy vs other weight loss medications

There is no single best GLP-1. Wegovy remains the most widely prescribed and insured option. Zepbound offers higher efficacy for those seeking maximum results. Saxenda suits patients who prefer daily dosing or need a gentler starting point. The right choice comes down to your goals, history, and how your body responds—and that’s a conversation worth having with a knowledgeable provider.

Frequently asked questions

What is the main difference between Wegovy and Zepbound? Wegovy activates one hormone pathway (GLP-1); Zepbound activates two (GLP-1 and GIP), which typically produces greater weight loss. Both are once-weekly injections, but Zepbound has a shorter real-world track record and more variable insurance coverage.

Can patients switch between GLP-1 medications? Yes. If a medication isn’t producing results, causes intolerable side effects, or loses insurance coverage, switching is a reasonable option. Your provider will guide the transition to ensure safe dosing throughout.

How long does treatment with these medications last? GLP-1 medications are intended for long-term chronic use, similar to blood pressure or diabetes medications. Duration depends on continued benefit and tolerability, and is reassessed regularly with your provider.

Do these medications work without diet and exercise changes? They’re most effective alongside lifestyle modifications. GLP-1 medications suppress appetite and reduce calorie intake, but building healthier habits alongside treatment produces the most durable results.

---

If you’re weighing Wegovy vs other weight loss medications and want personalized guidance, YooshMD’s telehealth program makes it simple. Dr. Roohani and the YooshMD team work with patients across California and Nevada to evaluate your health history, review insurance options, and prescribe the GLP-1 most aligned with your goals—all from home. Schedule a consultation today to find out which medication is right for you.